FDA NDC Directory · JSON-LD · Markdown

Syprine

NDC 0187-2120 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nametrientine hydrochloride
Labeler / ManufacturerBausch Health US LLC
Marketing categoryNew Drug Application (innovator) · App NDA019194
Dosage form / routeCAPSULE · ORAL
Active ingredientsTRIENTINE HYDROCHLORIDE (250 mg/1)
Marketing started19851108
Package count1

External sources

Source: openFDA. Public-domain (CC0).